Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.
Chen X, Habib S, Alexandru M, Chauhan J, Evan T, Troka JM, Rahimi A, Esapa B, Tull TJ, Ng WZ, Fitzpatrick A, Wu Y, Geh JLC, Lloyd-Hughes H, Palhares LCGF, Adams R, Bax HJ, Whittaker S, Jacków-Malinowska J, Karagiannis SN.
Chen X, et al. Among authors: chauhan j.
Cancers (Basel). 2024 Sep 25;16(19):3260. doi: 10.3390/cancers16193260.
Cancers (Basel). 2024.
PMID: 39409881
Free PMC article.
Review.